Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Clinical Biochemistry
|
April 7, 2018
DPD functional tests in plasma, fresh saliva and dried saliva samples as predictors of 5-fluorouracil exposure and occurrence of drug-related severe toxicity
Olavo Vicente Neto, Suziane Raymundo, Maria Alice Franzoi, et al.
Food & Function
|
August 29, 2025
Effect of aqueous green coffee extract (<i>Coffea canephora</i>) on the intestinal health of Wistar rats fed with a hypercaloric and hyperlipidic diet
Natália Alves de Souza Meneguelli, Manuella Domiciano Nascimento, Thainara Queiroz Pereira, et al.
International Journal of Food Sciences and Nutrition
|
March 21, 2022
Brown and golden flaxseed reduce intestinal permeability and endotoxemia, and improve the lipid profile in perimenopausal overweight women
Cíntia Tomaz Sant'Ana, Ariane Dias de Amorim, Ana Paula Gava, et al.
Molecular Nutrition & Food Research
|
July 9, 2025
Green Coffee Extract (Coffea canephora) Administered as Treatment Modulates Hepatic Markers and Attenuates Hepatic Steatosis in Rats Fed a High-Fat Diet
Manuella Domiciano do Nascimento, Natália Alves de Souza Meneguelli, Thainara Queiroz Pereira, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2025
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial
Maeve A Lowery, Lucjan S Wyrwicz, Do-Youn Oh, et al.
Future Oncology (London, England)
|
June 4, 2020
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412
Jean-Pascal Machiels, Yungan Tao, Barbara Burtness, et al.
The Lancet. Oncology
|
October 24, 2023
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
Sun Young Rha, Do-Youn Oh, Patricio Yañez, et al.
Lancet (London, England)
|
July 11, 2021
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
Christopher Sweeney, Sergio Bracarda, Cora N Sternberg, et al.
The New England Journal of Medicine
|
June 18, 2025
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
Ravindra Uppaluri, Robert I Haddad, Yungan Tao, et al.
Signal Transduction and Targeted Therapy
|
April 7, 2026
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study
Shuang Huang, Feng Liu, Song Qu, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Clinical Biochemistry
|
April 7, 2018
DPD functional tests in plasma, fresh saliva and dried saliva samples as predictors of 5-fluorouracil exposure and occurrence of drug-related severe toxicity
Olavo Vicente Neto, Suziane Raymundo, Maria Alice Franzoi, et al.
Food & Function
|
August 29, 2025
Effect of aqueous green coffee extract (<i>Coffea canephora</i>) on the intestinal health of Wistar rats fed with a hypercaloric and hyperlipidic diet
Natália Alves de Souza Meneguelli, Manuella Domiciano Nascimento, Thainara Queiroz Pereira, et al.
International Journal of Food Sciences and Nutrition
|
March 21, 2022
Brown and golden flaxseed reduce intestinal permeability and endotoxemia, and improve the lipid profile in perimenopausal overweight women
Cíntia Tomaz Sant'Ana, Ariane Dias de Amorim, Ana Paula Gava, et al.
Molecular Nutrition & Food Research
|
July 9, 2025
Green Coffee Extract (Coffea canephora) Administered as Treatment Modulates Hepatic Markers and Attenuates Hepatic Steatosis in Rats Fed a High-Fat Diet
Manuella Domiciano do Nascimento, Natália Alves de Souza Meneguelli, Thainara Queiroz Pereira, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2025
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial
Maeve A Lowery, Lucjan S Wyrwicz, Do-Youn Oh, et al.
Future Oncology (London, England)
|
June 4, 2020
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412
Jean-Pascal Machiels, Yungan Tao, Barbara Burtness, et al.
The Lancet. Oncology
|
October 24, 2023
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
Sun Young Rha, Do-Youn Oh, Patricio Yañez, et al.
Lancet (London, England)
|
July 11, 2021
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
Christopher Sweeney, Sergio Bracarda, Cora N Sternberg, et al.
The New England Journal of Medicine
|
June 18, 2025
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
Ravindra Uppaluri, Robert I Haddad, Yungan Tao, et al.
Signal Transduction and Targeted Therapy
|
April 7, 2026
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study
Shuang Huang, Feng Liu, Song Qu, et al.
Page
of 4